Effect of subthalamic deep brain stimulation on levodopa-induced dyskinesia in parkinson’s disease

Yonsei Medical Journal

Volumn 56, Issue 5, 2015, Pages 1316-1321

  Kim, Ji Hee ^a   Chang, Won Seok ^a   Jung, Hyun Ho ^a   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Deep brain stimulation; Dyskinesias; Parkinson disease; Subthalamic nucleus

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL EVALUATION; CONTROLLED STUDY; DYSKINESIA; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IMPLANTABLE PULSE GENERATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; RETROSPECTIVE STUDY; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; DYSKINESIA, DRUG-INDUCED; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84938860844     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2015.56.5.1316     Document Type: Article

References (36)

1. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Broussolle E, Perret JE, et al. Bilateral subthalamic nucleus stimulation for severe Parkinson’s disease. Mov Disord 1995;10:672-4.
2. Portman AT, van Laar T, Staal MJ, Rutgers AW, Journee HL, Leenders KL. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson’s disease. Parkinsonism Relat Disord 2006;12:143-8.
3. Østergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson’s disease and motor fluctuations. Mov Disord 2002;17:693-700.
4. Simonin C, Tir M, Devos D, Kreisler A, Dujardin K, Salleron J, et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson’s disease: a second honeymoon. J Neurol 2009;256:1736-41.
5. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21 Suppl 14: S290-304.
6. Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
7. Russmann H, Ghika J, Combrement P, Villemure JG, Bogousslavsky J, Burkhard PR, et al. L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction. Neurology 2004; 63:153-5.
8. Herzog J, Pinsker M, Wasner M, Steigerwald F, Wailke S, Deuschl G, et al. Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 2007;22:679-84.
9. Valldeoriola F, Pilleri M, Tolosa E, Molinuevo JL, Rumià J, Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinson’s disease: long-term follow-up of patients. Mov Disord 2002; 17:125-32.
10. Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, et al. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson’s disease. 2000. Neurology 2001;57(10 Suppl 3): S60-2.
11. Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000;57:461-5.
12. Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, et al. Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain 2002;125(Pt 3):575-83.
13. Molinuevo JL, Valldeoriola F, Tolosa E, Rumia J, Valls-Sole J, Roldan H, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000;57: 983-8.
14. Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumià J, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 2002;17:372-7.
15. Vesper J, Klostermann F, Stockhammer F, Funk T, Brock M. Results of chronic subthalamic nucleus stimulation for Parkinson’s disease: a 1-year follow-up study. Surg Neurol 2002;57:306-11.
16. Doshi PK, Chhaya NA, Bhatt MA. Bilateral subthalamic nucleus stimulation for Parkinson’s disease. Neurol India 2003;51:43-8.
17. Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, et al. Subthalamic nucleus stimulation in advanced Parkinson’s disease: blinded assessments at one year follow up. J Neurol Neurosurg Psychiatry 2004;75:1255-9.
18. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 2003;99:489-95.
19. Benabid AL, Benazzouz A, Limousin P, Koudsie A, Krack P, Piallat B, et al. Dyskinesias and the subthalamic nucleus. Ann Neurol 2000; 47(4 Suppl 1):S189-92.
20. Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003;60:690-4.
21. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson’s disease: twoyear follow-up. Neurology 2002;58:396-401.
22. Guridi J, Obeso JA, Rodriguez-Oroz MC, Lozano AA, Manrique M. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurgery 2008;62:311-23.
23. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain 1999;122 (Pt 6):1133-46.
24. Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson’s disease. Stereotact Funct Neurosurg 2006;84:176-9.
25. Nishikawa Y, Kobayashi K, Oshima H, Fukaya C, Yamamoto T, Katayama Y, et al. Direct relief of levodopa-induced dyskinesia by stimulation in the area above the subthalamic nucleus in a patient with Parkinson’s disease--case report. Neurol Med Chir (Tokyo) 2010;50:257-9.
26. Alterman RL, Shils JL, Gudesblatt M, Tagliati M. Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation lead. Case report. Neurosurg Focus 2004;17:E6.
27. Brodsky MA, Hogarth P, Nutt JG. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson’s disease. Mov Disord 2006;21:1487-90.
28. Peppe A, Pierantozzi M, Bassi A, Altibrandi MG, Brusa L, Stefani A, et al. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neu rosurg 2004;101:195-200.
29. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004;75: 1382-5.
30. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson’s disease: problems with the current model. Ann Neurol 2000;47(4 Suppl 1):S22-32.
31. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 2005;128 (Pt 10):2240-9.
32. Nimura T, Yamaguchi K, Ando T, Shibuya S, Oikawa T, Nakagawa A, et al. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study. J Neurosurg 2005;103:968-73.
33. Prensa L, Cossette M, Parent A. Dopaminergic innervation of human basal ganglia. J Chem Neuroanat 2000;20:207-13.
34. Figueiras-Méndez R, Marín-Zarza F, Antonio Molina J, Jiménez-Jiménez FJ, Ortí-Pareja M, Magariños C, et al. Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999;66:549-50.
35. Oyama G, Foote KD, Jacobson CE 4th, Velez-Lago F, Go C, Limotai N, et al. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease. Parkinsonism Relat Disord 2012;18: 814-8.
36. Hamani C, Saint-Cyr JA, Fraser J, Kaplitt M, Lozano AM. The subthalamic nucleus in the context of movement disorders. Brain 2004; 127(Pt 1):4-20.